Abbott Laboratories (ABT) Income from Continuing Operations (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Income from Continuing Operations data on file, last reported at 1077000000.0 in Q1 2026.

• For the quarter ending Q1 2026, Income from Continuing Operations fell 18.72% year-over-year to 1077000000.0; the trailing twelve-month figure through Mar 2026 stood at 6276000000.0 (down 53.52% YoY), and the FY2025 full-year result was 6524000000.0, down 51.32% from the prior year.
• Income from Continuing Operations declined to 1077000000.0 in Q1 2026, from 1776000000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 9229000000.0 in Q4 2024 to a low of 1033000000.0 in Q4 2022.
• A 5-year average of 1979941176.47 and a median of 1436000000.0 in 2023 frame the typical range for Income from Continuing Operations.
• Across the five-year window, Income from Continuing Operations jumped 478.98% in 2024 and tumbled 80.76% in 2025, its largest moves.
• Tracing ABT's Income from Continuing Operations over 5 years: stood at 1033000000.0 in 2022, then soared by 54.31% to 1594000000.0 in 2023, then jumped by 478.98% to 9229000000.0 in 2024, then plunged by 80.76% to 1776000000.0 in 2025, then tumbled by 39.36% to 1077000000.0 in 2026.
• Business Quant data shows ABT's Income from Continuing Operations at 1077000000.0 in Q1 2026, 1776000000.0 in Q4 2025, and 1644000000.0 in Q3 2025.